TOL-102

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameTOL-102
Drug Alias Namestem cell monoclonal antibody (Tolera Therapeutics)TOL-102
ClassificationCell and gene therapy > Cell therapy > Stem cell therapyBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsHematologic NeoplasmsPrecursor Cell Lymphoblastic Leukemia-Lymphoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Clinical)
Highest Status in ChinaN/A
Originator CompaniesTolera Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTolera Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsHematologic NeoplasmsPrecursor Cell Lymphoblastic Leukemia-Lymphoma

Other Information

ATC CodeN/A
Related LinksN/A